Literature DB >> 15816888

A comparison of long-term graft survival rates between the first and second donor kidney transplanted--the effect of a longer cold ischaemic time for the second kidney.

Louise Giblin1, Patrick O'Kelly, Dillie Little, David Hickey, John Donohue, Joseph J Walshe, Susan Spencer, Peter J Conlon.   

Abstract

Prolonged cold ischaemic time (CIT) is associated with delayed initial graft function and may also have a negative impact on long-term graft outcome. We carried out a study comparing the long-term graft survival rates between those recipients who received the first of a pair of donor kidneys versus the recipient of the second graft. Adult kidney transplant recipients who received one of a pair of donor kidneys at our institution between 1989-1995 were included. All recipients received a cyclosporin based immunosupression regimen. Graft survival rates were compared between the 2 groups at 1-, 3-, 5- and 10-year intervals. A total of 520 renal transplant grafts were included in this study. Mean donor age was 35.4 years. Groups were similar for recipient age, gender, number of HLA mismatches, transplant number for that patient and percentage PRA. CIT was the only variable that was significantly different between the two groups; mean of 19.93 h in the first group compared to 25.65 h in the second group. Graft survival rates for the first kidney were significantly better than the second kidney-graft survival at 1 year 88.5% versus 84.7%, at 3 years 81.8% versus 76.7%, at 5 years 72.2% versus 64.9% and at 10 years 55.2% versus 40% (p = 0.012). Patient survival rates were similar in both groups. In our experience, the long-term graft survival rates are significantly better for the first kidney transplanted compared to the second kidney.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816888     DOI: 10.1111/j.1600-6143.2005.00798.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

2.  Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database.

Authors:  Brian Y Young; Jagbir Gill; Edmund Huang; Steven K Takemoto; Bishoy Anastasi; Tariq Shah; Suphamai Bunnapradist
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-06       Impact factor: 8.237

3.  Influence of Cold Ischemia Time in Kidney Transplants From Small Pediatric Donors.

Authors:  Liise K Kayler; Michelle Lubetzky; Xia Yu; Patricia Friedmann
Journal:  Transplant Direct       Date:  2017-06-27

4.  Impact of Cold Ischemia Time in Kidney Transplants From Donation After Circulatory Death Donors.

Authors:  Liise Kayler; Xia Yu; Carlos Cortes; Michelle Lubetzky; Patricia Friedmann
Journal:  Transplant Direct       Date:  2017-06-23

5.  Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol.

Authors:  Michelle Willicombe; Anna Rizzello; Dawn Goodall; Vassilios Papalois; Adam G McLean; David Taube
Journal:  World J Transplant       Date:  2017-02-24

6.  Impact of Cold Ischemia Time on Outcomes of Deceased Donor Kidney Transplantation: An Analysis of a National Registry.

Authors:  Hessel Peters-Sengers; Julia H E Houtzager; Mirza M Idu; Martin B A Heemskerk; Ernst L W van Heurn; Jaap J Homan van der Heide; Jesper Kers; Stefan P Berger; Thomas M van Gulik; Frederike J Bemelman
Journal:  Transplant Direct       Date:  2019-04-25

7.  A Comparative Study of the Predictive Values of Urinary Acute Kidney Injury Markers Angiogenin and Kidney Injury Molecule 1 for the Outcomes of Kidney Allografts.

Authors:  Quentin Tavernier; Claire Tinel; Marion Rabant; Lise Morin; Dany Anglicheau; Nicolas Pallet
Journal:  Transplant Direct       Date:  2017-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.